Bal Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE083D01012
  • NSEID: BALPHARMA
  • BSEID: 524824
INR
83.50
-1.2 (-1.42%)
BSENSE

Nov 20

BSE+NSE Vol: 6.05 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 555664,
    "name": "Bal Pharma",
    "stock_name": "Bal Pharma",
    "full_name": "Bal Pharma Ltd",
    "name_url": "stocks-analysis/bal-pharma",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "83.50",
    "chg": -1.2,
    "chgp": "-1.42%",
    "dir": -1,
    "prev_price": "84.70",
    "mcapval": "135.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524824,
    "symbol": "BALPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE083D01012",
    "curr_date": "Nov 20",
    "curr_time": "",
    "bse_nse_vol": "6.05 k",
    "exc_status": "Active",
    "traded_date": "Nov 20, 2026",
    "traded_date_str": "2026 11 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/bal-pharma-555664-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Bal Pharma Ltd is Rated Hold by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/bal-pharma-ltd-is-rated-hold-by-marketsmojo-4267857",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/BalPharmaLtd_mojoScore_4267857.png",
        "date": "2026-11-19 10:10:57",
        "description": "Bal Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 11 November 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 November 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Bal Pharma Ltd Locks at Lower Circuit With 4.99% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/bal-pharma-ltd-hits-lower-circuit-amid-heavy-selling-pressure-4264199",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/11/BalPharmaLtd_stocks_hitting_lower_circuit_4264199.png",
        "date": "2026-11-16 14:00:09",
        "description": "At Rs 86.40, sellers were still queuing — but there were no buyers willing to take the other side. Bal Pharma Ltd locked at its lower circuit of 4.99% on 16 Nov 2026, with unfilled sell orders and a frozen price, reflecting a constrained exit environment for shareholders."
      },
      {
        "title": "Bal Pharma Surges 9.50% in a Week: Key Drivers Behind the Rally",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/bal-pharma-surges-950-in-a-week-key-drivers-behind-the-rally-4262020",
        "imagepath": "",
        "date": "2026-11-14 17:00:46",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Nov 09:</strong> Stock opens at Rs.83.41, up 1.37%</p>\n                    <p><strong>Nov 11:</strong> Continued gains with Rs.84.03 close (+0.74%)</p>\n                    <p><strong>Nov 12:</strong> Upper circuit hit at Rs.88.10 (+4.99%) amid strong buying and Q2 results</p>\n                    <p><strong>Nov 13:</strong> Week closes at Rs.90.10 (+2.12%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.82.28</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.90.10</div><div class=\"sta..."
      },
      {
        "title": "Bal Pharma Ltd is Rated Sell by MarketsMOJO",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/bal-pharma-ltd-is-rated-sell-by-marketsmojo-4245467",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/BalPharmaLtd_mojoScore_4245467.png",
        "date": "2026-10-31 10:10:13",
        "description": "Bal Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 October 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Bal Pharma Ltd Falls 14.87%: Downgrade and Lower Circuit Hit Drive Sharp Decline",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/bal-pharma-ltd-falls-1487-downgrade-and-lower-circuit-hit-drive-sharp-decline-4237503",
        "imagepath": "",
        "date": "2026-10-24 17:02:16",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>19 Oct:</strong> Downgrade to Sell rating by MarketsMOJO</p>\n                    <p><strong>23 Oct:</strong> Stock hits lower circuit limit at Rs.80.35</p>\n                    <p><strong>23 Oct:</strong> Seventh consecutive day of losses</p>\n                    <p><strong>23 Oct:</strong> Week closes at Rs.81.60 (-14.87%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.95.85</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.81.60</div><div class=\"stat-change negative\">-14.87%</div></..."
      },
      {
        "title": "Bal Pharma Ltd Upgraded to Hold as Technicals Improve and Valuation Attractiveness Increases",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/bal-pharma-ltd-upgraded-to-hold-as-technicals-improve-and-valuation-attractiveness-increases-4226111",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/BalPharmaLtd_mojoScore_4226111.png",
        "date": "2026-10-15 08:11:25",
        "description": "Bal Pharma Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and valuation metrics despite flat recent financial performance. The upgrade, effective from 14 October 2026, is driven primarily by a bullish shift in technical trends, attractive valuation relative to peers, and a stable financial trend, positioning the micro-cap pharmaceutical company as a cautious but watchful pick for investors."
      },
      {
        "title": "Bal Pharma Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/bal-pharma-ltd-surges-to-upper-circuit-amid-strong-buying-pressure-4223070",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/BalPharmaLtd_stocks_hitting_upper_circuit_4223070.png",
        "date": "2026-10-12 11:00:12",
        "description": "At Rs 97.71, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bal Pharma Ltd locked at its upper circuit of 5.0% on 12 Oct 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Bal Pharma Ltd Downgraded to Sell Amid Mixed Fundamentals and Technical Signals",
        "link": "https://researchintel.adityabirlamoney.com/news/stock-recommendation/bal-pharma-ltd-downgraded-to-sell-amid-mixed-fundamentals-and-technical-signals-4222293",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/10/BalPharmaLtd_mojoScore_4222293.png",
        "date": "2026-10-12 08:07:25",
        "description": "Bal Pharma Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 09 Oct 2026. This shift reflects a complex interplay of technical indicators, valuation metrics, financial trends, and quality assessments, signalling caution for investors despite some attractive valuation parameters."
      },
      {
        "title": "Bal Pharma Ltd Falls 13.43%: 4 Key Events Shaping This Week’s Decline",
        "link": "https://researchintel.adityabirlamoney.com/news/stocks-in-action/bal-pharma-ltd-falls-1343-4-key-events-shaping-this-weeks-decline-4221453",
        "imagepath": "",
        "date": "2026-10-10 17:01:07",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>5 Oct:</strong> Week opens at ₹107.60</p>\n                    <p><strong>6 Oct:</strong> Shares plunge to lower circuit amid heavy selling pressure</p>\n                    <p><strong>7 Oct:</strong> Upgraded to Hold as valuation and technicals improve; hits lower circuit again</p>\n                    <p><strong>9 Oct:</strong> Week closes at ₹93.15, down 13.43%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.107.60</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.93.15</div><div cla..."
      }
    ],
    "total": 53,
    "sid": "555664",
    "stock_news_url": "https://researchintel.adityabirlamoney.com/news/bal-pharma-555664"
  },
  "announcements": [
    {
      "caption": "Newspaper Publications - Unaudited Financial Results 30Th September 2026",
      "datetime": "12-Nov-2026",
      "details": "In Continuation of outcome of Board meeting dated 11th November 2026 published unaudited financial result for the 02nd quarter and half year ended 30th September 2026. Copy of the newspaper publication enclosed.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
      "datetime": "11-Nov-2026",
      "details": "As intimated vide our letter dated November 03 2026 Board of directors of the Company met on Wednesday November 11 2026 inter alia transacted the following business.",
      "source": "BSE"
    },
    {
      "caption": "Unaudited Standalone And Consolidated Financial Results For The Second Quarter And Half Year Ended On 30Th September 2026 Along With The Limited Review Report",
      "datetime": "11-Nov-2026",
      "details": "Enclosed unaudited standalone and consolidated Financial Result of Second quarter 30th September 2026 along with Limited Review Report",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Bal Pharma Ltd has declared <strong>12%</strong> dividend, ex-date: 17 Sep 26",
          "dt": "2026-09-17",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Newspaper Publications - Unaudited Financial Results 30Th September 2026

12-Nov-2026 | Source : BSE

In Continuation of outcome of Board meeting dated 11th November 2026 published unaudited financial result for the 02nd quarter and half year ended 30th September 2026. Copy of the newspaper publication enclosed.

Board Meeting Outcome for Outcome Of Board Meeting

11-Nov-2026 | Source : BSE

As intimated vide our letter dated November 03 2026 Board of directors of the Company met on Wednesday November 11 2026 inter alia transacted the following business.

Unaudited Standalone And Consolidated Financial Results For The Second Quarter And Half Year Ended On 30Th September 2026 Along With The Limited Review Report

11-Nov-2026 | Source : BSE

Enclosed unaudited standalone and consolidated Financial Result of Second quarter 30th September 2026 along with Limited Review Report

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Bal Pharma Ltd has declared 12% dividend, ex-date: 17 Sep 26

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available